Are consumer vagal nerve stimulation devices (Apollo Neuro, etc.) worth using?

Consumer vagal nerve stimulation (VNS) devices like Apollo Neuro deliver vibrotactile stimulation to the wrist or ankle, claiming to shift the autonomic nervous system toward parasympathetic dominance through sensory afferent pathways. Apollo Neuro has published one peer-reviewed study showing acute HRV improvement in healthy adults with their device. The acute effect is real: sensory input can transiently modify autonomic state through ascending afferent pathways. The question worth asking is whether this constitutes autonomic retraining or simply an acute state shift.

The evidence for sustained autonomic retraining from consumer VNS devices is Early (3): the mechanisms are biologically plausible, the acute effects are real, and the long-term autonomic training effect has not been demonstrated in rigorous trials with long-term follow-up. Compare this to resonance frequency breathing, which has 4–6 weeks of daily practice data showing measurable sustained HRV changes, or to structured aerobic exercise, which has decades of cardiovascular outcome data. The consumer VNS device may be a useful acute tool for men who find the tactile cue helpful for transitioning states. It is not a substitute for the interventions with established autonomic retraining evidence. At $300–400, it is also considerably more expensive than breath and exercise. (Apollo Neuro clinical study, Frontiers in Human Neuroscience, 2022)

Cardiologist's calibrated position, Early (3). Acute autonomic state shift: real. Sustained autonomic retraining: unproven.

What to do: If you find Apollo Neuro or similar devices genuinely useful for acute state transitions, use them as a supplement to the foundational interventions (resonance breathing, aerobic exercise, sleep, alcohol reduction), not as a replacement for them.

For the full picture, read Autonomic Sovereignty White Paper.